Journal of the Formosan Medical Association = Taiwan yi zhi · 2025
Joint position statement of the diagnosis and management of light chain amyloidosis and light chain cardiac amyloidosis by the Taiwan Society of Cardiology (TSOC) and the Hematology Society of Taiwan (HST).
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Yen-Wen, Wei Chao-Hung, Lin Yen-Hung, Huang Shang-Yi, Liu Yen-Wen, Tan Tran-Der, Yu Wen-Chung, Liu Chia-Jen, Hung Chung-Lieh, Ko Po-Shen, Yang Ning-I, Cho Shih-Feng, Huang Chun-Yao, Liao Chun-Kai, Jerry Teng Chieh-Lin, Chen Tsai-Yun, Chen Wen-Jone, Ko Bor-Sheng
Аннотация
Light chain (AL) amyloidosis, defined by the organ deposition of misfolded and aggregated amyloid light chain, is the most common subtype of systematic amyloidosis with an incidence rate of around 1 case per 100,000 person-years in Taiwan. Due to its rarity, and heterogeneous initial presentation depending on the affected organs, diagnosis and management of AL amyloidosis are challenging. To increase the awareness of AL amyloidosis across clinical specialties and provide evidence-based recommendations, the Taiwan Society of Cardiology (TSOC) and Hematology Society of Taiwan (HST) have jointly developed a position statement. The joint statement provides diagnosis and management recommendations for systematic AL amyloidosis and AL cardiac amyloidosis under Taiwan's medical context.